Review





Similar Products

97
Thermo Fisher gene exp lyve1 mm00475056 m1
Gene Exp Lyve1 Mm00475056 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gene exp lyve1 mm00475056 m1/product/Thermo Fisher
Average 97 stars, based on 1 article reviews
gene exp lyve1 mm00475056 m1 - by Bioz Stars, 2026-04
97/100 stars
  Buy from Supplier

94
Proteintech anti lyve 1
Anti Lyve 1, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti lyve 1/product/Proteintech
Average 94 stars, based on 1 article reviews
anti lyve 1 - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier

97
Thermo Fisher anti lyve1 antibody conjugated dynabeads
Anti Lyve1 Antibody Conjugated Dynabeads, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti lyve1 antibody conjugated dynabeads/product/Thermo Fisher
Average 97 stars, based on 1 article reviews
anti lyve1 antibody conjugated dynabeads - by Bioz Stars, 2026-04
97/100 stars
  Buy from Supplier

94
Proteintech lyve1
RFPL3 drives NSCLC tumorigenesis and lymphatic metastasis in vivo. A Macroscopic visualization reveals significantly larger tumor masses in the RFPL3 overexpression group; B Tumor growth curves demonstrate accelerated volume expansion in RFPL3-overexpressing xenografts compared to controls; C Quantitative analysis shows greater tumor weight in RFPL3-overexpressing tumors versus controls; D Representative immunohistochemical images showing upregulated expression of RFPL3, Ki67, and <t>LYVE1;</t> E Lymphatic metastasis model depicting enhanced popliteal lymph node metastasis in RFPL3-overexpressing group (yellow circles indicate metastatic foci); F Metastatic lymph nodes exhibit size increase with RFPL3 overexpression; G H&E staining confirms metastatic colonization in lymph nodes (arrows denote tumor clusters). 500 μm: 10×, 100 μm: 100×. **** P < 0.0001
Lyve1, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lyve1/product/Proteintech
Average 94 stars, based on 1 article reviews
lyve1 - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier

94
Proteintech lyve1 290
RFPL3 drives NSCLC tumorigenesis and lymphatic metastasis in vivo. A Macroscopic visualization reveals significantly larger tumor masses in the RFPL3 overexpression group; B Tumor growth curves demonstrate accelerated volume expansion in RFPL3-overexpressing xenografts compared to controls; C Quantitative analysis shows greater tumor weight in RFPL3-overexpressing tumors versus controls; D Representative immunohistochemical images showing upregulated expression of RFPL3, Ki67, and <t>LYVE1;</t> E Lymphatic metastasis model depicting enhanced popliteal lymph node metastasis in RFPL3-overexpressing group (yellow circles indicate metastatic foci); F Metastatic lymph nodes exhibit size increase with RFPL3 overexpression; G H&E staining confirms metastatic colonization in lymph nodes (arrows denote tumor clusters). 500 μm: 10×, 100 μm: 100×. **** P < 0.0001
Lyve1 290, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lyve1 290/product/Proteintech
Average 94 stars, based on 1 article reviews
lyve1 290 - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier

94
Proteintech lyve 1
RFPL3 drives NSCLC tumorigenesis and lymphatic metastasis in vivo. A Macroscopic visualization reveals significantly larger tumor masses in the RFPL3 overexpression group; B Tumor growth curves demonstrate accelerated volume expansion in RFPL3-overexpressing xenografts compared to controls; C Quantitative analysis shows greater tumor weight in RFPL3-overexpressing tumors versus controls; D Representative immunohistochemical images showing upregulated expression of RFPL3, Ki67, and <t>LYVE1;</t> E Lymphatic metastasis model depicting enhanced popliteal lymph node metastasis in RFPL3-overexpressing group (yellow circles indicate metastatic foci); F Metastatic lymph nodes exhibit size increase with RFPL3 overexpression; G H&E staining confirms metastatic colonization in lymph nodes (arrows denote tumor clusters). 500 μm: 10×, 100 μm: 100×. **** P < 0.0001
Lyve 1, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lyve 1/product/Proteintech
Average 94 stars, based on 1 article reviews
lyve 1 - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier

Image Search Results


RFPL3 drives NSCLC tumorigenesis and lymphatic metastasis in vivo. A Macroscopic visualization reveals significantly larger tumor masses in the RFPL3 overexpression group; B Tumor growth curves demonstrate accelerated volume expansion in RFPL3-overexpressing xenografts compared to controls; C Quantitative analysis shows greater tumor weight in RFPL3-overexpressing tumors versus controls; D Representative immunohistochemical images showing upregulated expression of RFPL3, Ki67, and LYVE1; E Lymphatic metastasis model depicting enhanced popliteal lymph node metastasis in RFPL3-overexpressing group (yellow circles indicate metastatic foci); F Metastatic lymph nodes exhibit size increase with RFPL3 overexpression; G H&E staining confirms metastatic colonization in lymph nodes (arrows denote tumor clusters). 500 μm: 10×, 100 μm: 100×. **** P < 0.0001

Journal: Discover Oncology

Article Title: Exploring targeted therapies against RFPL3 for non-small cell lung cancer with lymph node metastasis

doi: 10.1007/s12672-025-04116-4

Figure Lengend Snippet: RFPL3 drives NSCLC tumorigenesis and lymphatic metastasis in vivo. A Macroscopic visualization reveals significantly larger tumor masses in the RFPL3 overexpression group; B Tumor growth curves demonstrate accelerated volume expansion in RFPL3-overexpressing xenografts compared to controls; C Quantitative analysis shows greater tumor weight in RFPL3-overexpressing tumors versus controls; D Representative immunohistochemical images showing upregulated expression of RFPL3, Ki67, and LYVE1; E Lymphatic metastasis model depicting enhanced popliteal lymph node metastasis in RFPL3-overexpressing group (yellow circles indicate metastatic foci); F Metastatic lymph nodes exhibit size increase with RFPL3 overexpression; G H&E staining confirms metastatic colonization in lymph nodes (arrows denote tumor clusters). 500 μm: 10×, 100 μm: 100×. **** P < 0.0001

Article Snippet: Subsequently, primary tumor and popliteal lymph node tissues were paraffin-embedded for subsequent analyses, including H&E staining and IHC for RFPL3, LYVE1 (ProteinTech, #28321-1-AP) and Ki67 (ProteinTech, #27309-1-AP).

Techniques: In Vivo, Over Expression, Immunohistochemical staining, Expressing, Staining